Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

A La Marca, SK Sunkara - Human reproduction update, 2014 - academic.oup.com
BACKGROUND The main objective of individualization of treatment in IVF is to offer every
single woman the best treatment tailored to her own unique characteristics, thus maximizing …

AMH: An ovarian reserve biomarker in assisted reproduction

C Peluso, FLA Fonseca, IF Rodart, V Cavalcanti… - Clinica Chimica …, 2014 - Elsevier
Ovarian reserve tests provide knowledge of a possible response to controlled ovarian
hyperstimulation in patients undergoing assisted reproduction treatment, allowing …

Plasma anti-mullerian hormone: an endocrine marker for in vitro embryo production from Bos taurus and Bos indicus donors

BM Guerreiro, EOS Batista, LM Vieira… - Domestic animal …, 2014 - Elsevier
The aim of this study was to evaluate the association between plasma anti-mullerian
hormone (AMH) concentration and in vitro embryo production (IVP) from Bos taurus …

Mitochondrial SIRT3 and its target glutamate dehydrogenase are altered in follicular cells of women with reduced ovarian reserve or advanced maternal age

L Pacella-Ince, DL Zander-Fox, M Lane - Human reproduction, 2014 - academic.oup.com
STUDY QUESTION Is the activity of sirtuin 3 (SIRT3) altered in granulosa and cumulus cells
from young women with reduced ovarian reserve or women of advanced maternal age …

Ovarian reserve screening: a scientific and ethical analysis

K Tremellen, J Savulescu - Human reproduction, 2014 - academic.oup.com
Ovarian reserve (OR) screening of the general population is generally not advocated as it
has not been conclusively established to reflect immediate potential for natural conception …

Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology

K Lukaszuk, J Liss, M Kunicki, G Jakiel… - Reproductive …, 2014 - Elsevier
In the present study, we evaluated the clinical value of the following parameters: basal anti-
Müllerian hormone (AMH), follicle-stimulating hormone (FSH), inhibin B and antral follicle …

AMH concentration is not related to effective time to pregnancy in women who conceive naturally

I Streuli, J de Mouzon, C Paccolat, C Chapron… - Reproductive …, 2014 - Elsevier
This study determined whether anti-Müllerian hormone (AMH) concentration influences the
time necessary to conceive a live-born child–effective time to pregnancy (eTTP)–in a …

Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH …

E Tsakos, A Tolikas, A Daniilidis… - Archives of gynecology …, 2014 - Springer
Aim To compare the efficacy of three methods: the levels of anti-müllerian hormone (AMH),
the levels of follicle stimulating hormone (FSH) and the antral follicle count (AFC), for the …

Mitochondrial SIRT5 is present in follicular cells and is altered by reduced ovarian reserve and advanced maternal age

L Pacella-Ince, DL Zander-Fox… - Reproduction, Fertility and …, 2014 - CSIRO Publishing
Women with reduced ovarian reserve or advanced maternal age have an altered metabolic
follicular microenvironment. As sirtuin 5 (SIRT5) senses cellular metabolic state and post …

[HTML][HTML] Anti-Müllerian hormone: determination of ovarian reserve in early breast cancer patients

C Bozza, F Puglisi, M Lambertini… - Endocrine-related …, 2014 - erc.bioscientifica.com
Breast cancer is the most common invasive cancer in women of reproductive age. In young
women, chemotherapy may induce amenorrhea: it is still uncertain how to assess …